[Neuropathic pain].
Makoto
M
Tsuda
Katsuyuki
K
Matsushita
Kazuhide
K
Inoue
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D004195:Disease Models, Animal; D055808:Drug Discovery; D005786:Gene Expression Regulation; D006801:Humans; D050835:Interferon Regulatory Factors / Q000502:physiology; D017628:Microglia / Q000473:pathology / Q000502:physiology; D058990:Molecular Targeted Therapy; D009437:Neuralgia / Q000188:drug therapy / Q000209:etiology / Q000235:genetics; D058848:Receptors, Purinergic P2X4; D058925:Receptors, Purinergic P2Y12; D051195:Toll-Like Receptor 2; D000099185:Interferon Regulatory Factor-8
D000929:Antidepressive Agents, Tricyclic; D050835:Interferon Regulatory Factors; D058848:Receptors, Purinergic P2X4; D058925:Receptors, Purinergic P2Y12; D051195:Toll-Like Receptor 2; D000099185:Interferon Regulatory Factor-8; C495342:TLR2 protein, human